View of Immunoexpression of markers related to the human epidermal growth factor receptor-type 2 (HER2) pathway in cases of pure positive HER2 breast carcinoma treated with trastuzumab

Return to Article Details Immunoexpression of markers related to the human epidermal growth factor receptor-type 2 (HER2) pathway in cases of pure positive HER2 breast carcinoma treated with trastuzumab Download Download PDF